Anlon Healthcare
AHCLNSE

Anlon Healthcare

₹14.550.34 (2.39%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
13.97
Today’s high
14.70
52 week low
9.08
52 week high
17.28
Open price
14.14
Previous close
14.21
Live volume
32,03,483
Lower circuit
11.64
Upper circuit
17.46

Fundamentals

Market Cap
₹756Cr
ROE
13.26%
P/E Ratio(TTM)
25.87
EPS(TTM)
0.55
P/B Ratio
3.61
Dividend Yield
0.00%
Industry P/E
41.93
Book Value
3.95
Debt to Equity
0.22
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹87.62
+72.14%
Profit (Cr)
₹8.28
-25.20%
0255075100
Mar '25
Jun '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+79%
3Y CAGR+28%
Profit growthValue
1Y (TTM)-50%
3Y CAGR+477%

About

Anlon Healthcare Limited is a pharmaceutical company engaged in the contract development and manufacturing organization (CDMO) business, specializing in complex injectables and providing end-to-end solutions.;
CEO/MD
Punitkumar R Rasadia
Founded in
2013
NSE symbol
AHCL

Shareholding Pattern

Jun '26
Mar '26
Dec '25
Sep '25
Aug '25
Promoters
70.26%
Retail And Others
29.74%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,880.60
-19.40 (0.40%)
L
    H
    22,422.5630.55.34
    ₹873.85
    +35.20 (4.20%)
    L
      H
      20,770.3431.364.4
      ₹8,191.00
      +115.50 (1.43%)
      L
        H
        20,228.38107.8723.18
        ₹1,382.40
        -0.50 (0.04%)
        L
          H
          19,255.4628.924.93
          Livesquawk
          Anlon Healthcare anticipates 30% revenue growth over 3 years via acquisitions, new products, and capacity expansion. The growth is attributed to strategic initiatives including acquisitions and increasing production capacity.
          Livesquawk
          Anlon Healthcare's Q1 standalone net profit rose to ₹48M from ₹35M YoY.
          2026
          30
          Jul
          Quarterly Result
          Release date
          29
          May
          Quarterly & Annual Result
          Release date

          24
          Apr
          Split
          Ex date
          2:10
          Ratio

          For each share you hold, you will receive 5 shares with face value of ₹2.0 each
          Split Ratio2:10
          Ex date24 Apr ‘26
          Record date24 Apr ‘26
          Announcement date6 Mar ‘26

          24
          Apr
          Bonus
          Ex date
          1:1
          Ratio

          For every 1 shares you hold, you will receive 1 additional shares
          Bonus ratio1:1
          Ex date24 Apr ‘26
          Record date24 Apr ‘26
          Announcement date10 Apr ‘26

          10
          Apr
          Bonus
          Announced
          1:1
          Ratio

          For every 1 shares you hold, you will receive 1 additional shares
          Bonus ratio1:1
          Ex date24 Apr ‘26
          Record date24 Apr ‘26
          Announcement date10 Apr ‘26

          6
          Mar
          Split
          Announced
          2:10
          Ratio

          For each share you hold, you will receive 5 shares with face value of ₹2.0 each
          Split Ratio2:10
          Ex date24 Apr ‘26
          Record date24 Apr ‘26
          Announcement date6 Mar ‘26
          9
          Feb
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks